[{"AccountsPayableCurrent_0_Q2_USD":7261000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":18134000.0,"PurchaseObligationDueInSecondAndThirdYear_0_Q2_USD":3100000.0,"PurchaseObligationDueInNextTwelveMonths_0_Q2_USD":15800000.0,"PurchaseObligation_0_Q2_USD":18900000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":74800.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":292000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_2_Q2_USD":241597000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":345833000.0,"PrepaidInsurance_0_Q2_USD":10234000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":15984000.0,"PreferredStockValue_0_Q2_USD":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":22840902.0,"PreferredStockParOrStatedValuePerShare_0_Q2_GBP":0.002,"PreferredStockDividendsPerShareDeclared_2_Q2_USD":0.0,"PreferredStockConvertibleConversionRatio_0_Q2_pure":1.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":74000.0,"PaymentsToAcquireInProcessResearchAndDevelopment_2_Q2_USD":4596000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":12000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-2699000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-191000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":1094000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":3315000.0,"OtherAssetsCurrent_0_Q2_USD":444000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":395000.0,"OperatingIncomeLoss_2_Q2_USD":-277478000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":28276000.0,"OperatingIncomeLoss_1_Q2_USD":-41287000.0,"ResearchAndDevelopmentInProcess_1_Q2_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-284724000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":57309693.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":63516656.0,"ValueAddedTaxReceivable_0_Q2_USD":1365000.0,"TemporaryEquitySharesOutstanding_0_Q2_shares":0.0,"TemporaryEquitySharesIssued_0_Q2_shares":0.0,"TemporaryEquitySharesAuthorized_0_Q2_shares":0.0,"TemporaryEquityParOrStatedValuePerShare_0_Q2_GBP":0.0001,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":0.0,"StockRepurchasedAndRetiredDuringPeriodValue_2_Q2_USD":12000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":50000.0,"StockIssued1_2_Q2_USD":262698000.0,"StockholdersEquity_0_Q2_USD":585642000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":6.89,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":5.84,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":5.84,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":6.98,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":10530410.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":160400000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":6.98,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":11414307.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":833897.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":4.4,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":518857.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":9200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":8662500.0,"ShareBasedCompensation_2_Q2_USD":5960000.0,"SaleOfStockConsiderationReceivedOnTransaction_0_Q2_USD":344100000.0,"ResearchAndDevelopmentInProcess_2_Q2_USD":220454000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"NetIncomeLoss_2_Q2_USD":-280142000.0,"NetIncomeLoss_1_Q2_USD":-41451000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-276827000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-40357000.0,"CommonStockValue_0_Q2_USD":252000.0,"CommonStockSharesOutstanding_0_Q2_shares":89899419.0,"CommonStockSharesIssued_0_Q2_shares":89899419.0,"CommonStockSharesAuthorized_0_Q2_shares":89899419.0,"CommonStockParOrStatedValuePerShare_0_Q2_GBP":0.002,"CommitmentsAndContingencies_0_Q2_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":608794000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":613759000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":613759000.0,"CashAcquiredFromAcquisition_2_Q2_USD":68038000.0,"AssetsCurrent_0_Q2_USD":643682000.0,"Assets_0_Q2_USD":643757000.0,"AssetAcquisitionContingentConsiderationLiabilityNoncurrent_0_Q2_USD":33930000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":11518752.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":0.0,"AmortizationOfDebtDiscountPremium_1_Q2_USD":0.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":5960000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3229000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q2_USD":8800000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3229000.0,"AdditionalPaidInCapital_0_Q2_USD":866889000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":3225000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":3271000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":16924000.0,"AccruedInsuranceCurrent_0_Q2_USD":8367000.0,"ConvertibleNotesPayableCurrent_0_Q2_USD":0.0,"DebtConversionConvertedInstrumentAmount1_2_Q2_USD":6250000.0,"DebtInstrumentDecreaseForgiveness_2_Q2_USD":6199000.0,"DebtInstrumentUnamortizedDiscount_0_Q2_USD":700000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-45512000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":63368000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":587710000.0,"LoansPayableCurrent_0_Q2_USD":0.0,"LiabilitiesCurrent_0_Q2_USD":24185000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":643757000.0,"Liabilities_0_Q2_USD":58115000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":35000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":27000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":4783000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":4706000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":2159000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":17436000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":57309693.0,"GeneralAndAdministrativeExpense_1_Q2_USD":11841000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q2_USD":0.0,"ForeignCurrencyExchangeRateTranslation1_0_Q2_USD\/GBP":0.73,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":41800000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":907000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":3228000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.65,"EarningsPerShareDiluted_2_Q2_USD":-4.89,"EarningsPerShareBasic_2_Q2_USD":-4.89,"EarningsPerShareBasic_1_Q2_USD":-0.65,"DerivativeLiabilitiesCurrent_0_Q2_USD":0.0,"DepreciationDepletionAndAmortization_2_Q2_USD":9000.0,"Depreciation_2_Q2_USD":6807.0,"Depreciation_1_Q2_USD":5434.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":0.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":63516656.0,"Ticker":"CNTA","CIK":"1847903","name":"CENTESSA PHARMACEUTICALS PLC","OfficialName":"Centessa Pharmaceuticals plc American Depositary Shares","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"866864446.0","Country":"United Kingdom","Sector":"nan","Industry":"nan","Market":"NASDAQ","SP500":"nan","filed":"20210816"}]